PMID: 33579961

Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.

Buus Richard, Szijgyarto Zsolt, Schuster Eugene F, Xiao Hui, Haynes Ben P, Sestak Ivana, Cuzick Jack, Paré Laia, Seguí Elia, Chic Nuria

NPJ breast cancer · 2025

Vol. 7, Issue 1, pp. 15

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.